<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03277378</url>
  </required_header>
  <id_info>
    <org_study_id>SJM-CIP-10116</org_study_id>
    <nct_id>NCT03277378</nct_id>
  </id_info>
  <brief_title>EValuating Anatomic vErsus TaRgeted Lead Placement for BurstDR TherapY During the Trial</brief_title>
  <acronym>DELIVERY</acronym>
  <official_title>Randomized, ControlleD, Single Blind, ProspEctive, MuLtIcenter Study EValuating Anatomic vErsus TaRgeted Lead Placement for BurstDR TherapY During the Trial Evaluation Period. (DELIVERY)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, controlled, single blind, multi-center clinical investigation comparing
      success rates for anatomically placed leads to conventional, targeted lead placement for
      BurstDR™ during the trial evaluation period with the St Jude Medical™ Invisible Trial System.
      Subjects will be blinded to treatment group and randomized in a 1:1 ratio as follows:

      Group 1 (AB): anatomic lead placement followed by BurstDR™ stimulation during an initial
      trial evaluation period Group 2 (TB): targeted lead placement followed by BurstDR™
      stimulation during an initial trial evaluation period

      If the subject qualifies for permanent system implant according to pre-defined criteria after
      the initial trial evaluation period, the subject will exit the clinical investigation and
      continue their treatment per the physician's standard of care. Subjects who do not qualify
      for permanent system implant according to pre-defined criteria after the initial trial
      evaluation period may participate in an extended trial evaluation period, per physician
      discretion, during which they will be programmed with tonic stimulation. Subjects continuing
      to an extended trial evaluation period will be followed through the completion of the
      extended trial period. At the end of the extended trial evaluation period, subjects will exit
      the clinical investigation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 22, 2017</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Qualification rate for permanent implant</measure>
    <time_frame>Up to 3 weeks</time_frame>
    <description>The primary endpoint is the qualification rate for permanent system implant at the end of the initial trial evaluation period.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">288</enrollment>
  <condition>Chronic, Intractable Pain of the Trunk and/or Lower Limbs</condition>
  <arm_group>
    <arm_group_label>Group 1 (AB)</arm_group_label>
    <description>Group 1 (AB): anatomic lead placement followed by BurstDR™ stimulation during an initial trial evaluation period</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2 (TB)</arm_group_label>
    <description>Group 2 (TB): targeted lead placement followed by BurstDR™ stimulation during an initial trial evaluation period</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>lead placement followed by BurstDR stimulation</intervention_name>
    <description>lead placement followed by BurstDR stimulation</description>
    <arm_group_label>Group 1 (AB)</arm_group_label>
    <arm_group_label>Group 2 (TB)</arm_group_label>
    <other_name>Spinal Cord Stimulation non-surgical Leads</other_name>
    <other_name>Spinal Cord Stimulation Clinician Programmer</other_name>
    <other_name>Spinal Cors Stimulation Patient Controller</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The intended population for this clinical investigation is patients over the age of 18
        years that have chronic, intractable pain of the trunk and/or lower limbs and have been
        recommended by a physician for spinal cord stimulation therapy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient indicated for Spinal Cord Stimulation therapy in accordance with the approved
             labeling.

          2. Patient's pain profile indicates appropriate lead placement would be at one or more
             levels from T7 to T10, to achieve pain coverage.

          3. Patient has a baseline score on the Numerical Rating Scale ≥6 over the past 24 hours
             for 'average overall pain'specific to the area(s) of chronic pain that will be treated
             with spinal cord stimulation.

          4. Patient is considered by the Study Investigator as a candidate for implantation of a
             spinal cord stimulator system according to the system Instructions for Use.

          5. Patient is &gt;18 years of age at the time of enrollment.

          6. Patient is willing to adhere to the study requirements, including compliance with and
             completion of all study visits.

          7. Patient has signed and received a copy of the Ethical Committee/Independent Review
             Board approved informed consent.

        Exclusion Criteria:

          1. Patient currently has a spinal cord stimulation system implanted.

          2. Patient has previously failed a spinal cord stimulation therapy (either trial system
             evaluation or permanent system implant).

          3. Patient has a primary diagnosis of Peripheral Vascular Disease (PVD), Angina Pectoris,
             or Chronic Migraine.

          4. Patient is scheduled to undergo an on-the-table trial evaluation (aka all-in-one
             procedure)

          5. Patient is scheduled to be implanted with (a) surgical paddle trial lead(s).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nicole Harbert</last_name>
    <phone>+1 975264841</phone>
    <email>Nicole.Harbert@abbott.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Jason Edward Pope, MD</name>
      <address>
        <city>Santa Rosa</city>
        <state>California</state>
        <zip>95403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Stender</last_name>
      <phone>844-527-7369</phone>
    </contact>
    <investigator>
      <last_name>Jason E Pope, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Comprehensive Spine Institute</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33765</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rosalyn Burgman</last_name>
      <phone>727-228-1004</phone>
    </contact>
    <investigator>
      <last_name>Ashraf Ragab, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Pain Institute</name>
      <address>
        <city>Merritt Island</city>
        <state>Florida</state>
        <zip>32953</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thalia Newton</last_name>
      <phone>321-784-8211</phone>
    </contact>
    <investigator>
      <last_name>Michael Esposito, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Pain Institute Winter Park</name>
      <address>
        <city>Winter Park</city>
        <state>Florida</state>
        <zip>32789</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Berta Kee</last_name>
      <phone>407-622-5766</phone>
      <phone_ext>1412</phone_ext>
      <email>berta.kee@prospirapc.com</email>
    </contact>
    <investigator>
      <last_name>Cherian Sajan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rush University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathaniel Froikin</last_name>
      <phone>312-942-2741</phone>
    </contact>
    <investigator>
      <last_name>Timothy Lubenow, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Pain Care</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89052</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Lowe</last_name>
      <phone>702-445-4032</phone>
    </contact>
    <investigator>
      <last_name>Michael Fishell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nevada Advanced Pain Specialists</name>
      <address>
        <city>Reno</city>
        <state>Nevada</state>
        <zip>89511</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachael Yetter</last_name>
      <phone>775-284-8650</phone>
    </contact>
    <investigator>
      <last_name>Denis G. Patterson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dayton Outpatient</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45432</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>TBD TBD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Spinal Diagnostics</name>
      <address>
        <city>Tualatin</city>
        <state>Oregon</state>
        <zip>97062</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ursula Kuhn</last_name>
      <phone>503-885-1515</phone>
      <email>ursulak@spinaldx.com</email>
    </contact>
    <investigator>
      <last_name>Robert Heros, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rhode Island Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karina Bertsch</last_name>
      <phone>401-793-9177</phone>
    </contact>
    <investigator>
      <last_name>Alexios Carayannopoulos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Precision Spine Care</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeanetta Patterson</last_name>
      <phone>903-531-0566</phone>
      <email>jeanettap@psctyler.com</email>
    </contact>
    <investigator>
      <last_name>Mark Hackbarth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Spine and Nerve Center</name>
      <address>
        <city>Charleston</city>
        <state>West Virginia</state>
        <zip>25301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Young</last_name>
      <email>Amy.Young@ThomasHealth.org</email>
    </contact>
    <investigator>
      <last_name>Timothy Deer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Mary's Hospital</name>
      <address>
        <city>Huntington</city>
        <state>West Virginia</state>
        <zip>25701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Staicy Mathew</last_name>
      <phone>917-530-1936</phone>
    </contact>
    <investigator>
      <last_name>Rudy Malayil, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Elisabethinen GmbH</name>
      <address>
        <city>Graz</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Kern, MD</last_name>
      <email>michael.kern@elisabethinen.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal University Hospital</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <zip>S7N 5E5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cheri Derksen</last_name>
      <email>cheri.derksen@usask.ca</email>
    </contact>
    <investigator>
      <last_name>Ivar Mendez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sana Kliniken Duisburg Gm.bH</name>
      <address>
        <city>Duisburg</city>
        <zip>47055</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Schu, MD</last_name>
      <email>stefan.schu@sana.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medizinische Einrichtungen der Universität Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philipp Slotty, MD</last_name>
      <email>Slotty@med.uni-duesseldorf.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Gera -Zentrum für interdisziplinäre Schmerztherapie</name>
      <address>
        <city>Gera</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinikum Nürnberg Sud</name>
      <address>
        <city>Nürnberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fondazione Salvatore Maugeri</name>
      <address>
        <city>Pavia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Demartini, MD</last_name>
      <email>laura.demartini@icsmaugeri.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stichting Rijnstate Ziekenhuis - Velp</name>
      <address>
        <city>Velp</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Kallewaard, MD</last_name>
      <email>jkallewaard@rijnstate.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Canada</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2017</study_first_submitted>
  <study_first_submitted_qc>September 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 11, 2017</study_first_posted>
  <last_update_submitted>April 20, 2018</last_update_submitted>
  <last_update_submitted_qc>April 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Intractable</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

